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Butyrylcholinesterase level in poisoned patients with 
phosphide compounds 
 
Abstract 
Background: Metal phosphides are widely used as a rodenticide and insecticide and 
poisoning with these substances has a very high mortality. The aim of this study was to 
evaluate the butyrylcholinesterase (BuCh) level in poisoning with metal phosphides. 
Methods: In this case series study, 60 poisoned patients with zinc phosphide (ZnP) and 
aluminum phosphide (ALP) who was admitted to poisoning ward in Hamadan, Iran, 
enrolled in the study and BuCh level was measured. The sex, age, amount of ingestion, 
time of consumption, signs and symptoms, ECG and arterial blood gas (ABG) changes and 
clinical outcomes were evaluated.  
Results: Most (58.3%) patients were males, the mean age was 32.76±17.65 years. The 
average amount of ingestion was 7.5±4.6 and 2.5±2.96 gr for ZnP and ALP, respectively. 
Most signs and symptoms were hypotension (97%), nausea and vomiting (82%) and 
abdominal pain (32%). The average amount of BuCh level in all patients was 
5163.25±2158.31 U/L, that's while in ZnP and ALP poisoned patients was 5608±1577 U/L 
and 4721.46±2562U/L respectively. The most dysrhythmia (26.7%) was sinus tachycardia. 
Acidosis was seen in 33.3% of patients. 14 patients died after hospital admission, which 
caused a 23.3% fatality rate. 
Conclusion: Our results showed that, there was no significant change in BuCh level in 
poisoned patients with phosphide compounds. 
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Today, the use of pesticides in the world is considered as a recognized health 
problem. It is estimated that around 30% of global suicides are due to pesticide self-
poisoning (1). Metal phosphides pesticides are highly toxic, low cost, and are easily accessible as 
rodenticide agents and used for self-poisoning (2). Zinc phosphide (ZnP) and aluminum 
phosphide (ALP) are among the most important metal phosphides. Poisoning with these 
agents is frequently seen in India, Srilanka and Iran (3-8). In a recent study, the incidence 
of fatal aluminum phosphide poisoning cases referred for phosphine analysis was 5.22 and 
37.02 per million of population of Tehran, Iran in 2006 and 2013, respectively (9).The 
mechanism of toxicity is not clearly defined. ZnP and ALP toxicity is related to the production of 
phosphine gas. Phosphine inhibits cytochrome c oxidase and causes mitochondrial 
destruction and inhibits oxidative respiration which leads to anaerobic metabolism, severe 
metabolic acidosis, multi-organ dysfunction and death (10-13). Phosphine can lead to 
severe cardiac suppression and cardiogenic shock (14). One of the proposed mechanisms of 
toxicity is the reduction of the true cholinesterase and serum cholinesterase (butyrylcholinesterase) 
enzyme, but usually do not show obvious clinical manifestations (15-17). 
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According to the few human studies on this subject in the 
world and particularly in Iran, and considering that it was not 
possible for us to measure true cholinesterase enzyme level, 
this study aimed to measure  the butyrylcholinesterase 
(BuCh) level in human poisoned patients by ZnP and ALP. 
We assessed symptoms and signs, ECG and ABG changes, 
liver and kidney function tests and outcome between ZnP 
and ALP poisoned patient groups.  
 
 
Methods 
Study design: This was a case series study and all poisoned 
patients with metal phosphides include ZnP and ALP was 
investigated. This study was conducted in a 12-month period 
from December 2016 to December 2017 and all of the 
poisoned patients with ZnP or ALP who referred to the 
hospital during the study period were enrolled in the study. 
Totally 60 patients, including 30 ZnP and 30 ALP poisoned 
patients were investigated. 
Setting: The study was carried out at Farshchian Hospital in 
Hamadan (west Iran). This hospital is a poison center that covers 
about 1,500,000 people in the Hamadan province.  This is the 
only tertiary hospital for the poisoned patients in this province.  
Data collection: The diagnosis of ZnP and ALP 
consumption were determined based on the history, clinical 
signs and symptoms and paraclinical tests such as SGOT, 
SGPT, BUN, creatinine, arterial blood gas (ABG), ECG 
were also checked out. In addition, BuCh was measured by 
BuCh Elisa kits of Pars Azmoon Company. The reference 
range of this kit was 3930–11500 U/L. Demographic data, 
clinical and paraclinical signs, BuCh level and outcome of 
poisoning were compared between ZnP and ALP poisoned 
patients. Those patients who consumed ZnP and ALP lower 
than toxic dosage and all patients who had one of the factors 
affecting BuCh level, such as consumption of  organophosphates 
or carbamates, pregnancy and chronic liver diseases were 
excluded. The data were entered into the SPSS statistical 
software, Version 21. The analysis was mostly descriptive in 
nature; differences between two groups were evaluated with 
the unpaired student’s t-test and chi-square test. Of all 
comparisons, a p-value less than 0.05 was considered significant. 
 
 
Results 
 In 60 poisoned patients by phosphide compounds 35 
(58.3%) were males and 25 (41.7%) were females. The mean 
age of the poisoned patients was 32.76±17.65 years 
(30.46±19.82 years in ZnP and 35.06±15.16 years in ALP, 
respectively). Most patients (50 patients or 83%) had 
ingested phosphide compounds less than 6 hours before 
referring to the emergency ward and for the rest 10 patients 
(17%) the referral time was more than 6 hours. 14 out of 60 
poisoned patients died after hospital admission, which 
showed a 23.3% fatality rate among patients. The 
demographic data, time of ingestion and final outcome in 
ZnP and ALP poisoned patients are presented in table 1. 
 
Table 1: Demographic characteristics of 60 hospitalized 
patients with phosphide compounds consumption. 
 
Variables ZnP* 
(N%) 
ALP** 
(N%) 
Pvalue 
Sex 
Male 
Female 
 
14 (46.7) 
16 (53.3) 
 
21(70) 
9(30) 
 
0.06 
Age (y) 
10-20 
21-30 
31-40 
41-50 
>50 
 
11(36.7) 
11(36.7) 
3(10) 
1(3.3) 
4(13.3) 
 
6(20) 
7(23.3) 
7(23.3) 
4(13.3) 
6(20) 
 
 
 
0.32 
Time of ingestion (h) 
<2 
2-6 
>6 
 
12(40) 
11(36.7) 
7(23.3) 
 
13(43.3) 
14(46.7) 
3(10) 
 
 
0.37 
Fatality rate 4(13.3) 10(33.3) 0.06 
* Zine phosphide        ** Aluminium phosphide 
 
The average ingestion of ZnP was 7.5±4.68 gr. 23 
(76.7%) patients had ingested 5 gr, 2 (6.7%) patients 
ingested 10 gr and 5 (16.6%) patients had more than 10 gr. 
The average ingestion of the ALP was 2.5±2.96 gr; from 
them 13 (43.3%) patients ingested 0.5 gr, 4 (13.3%) patients 
consumed ate 1.5 gr, 8 (26.7%) patients had 3 gr and 5 
(16.7%) patients ingested more than 3 gr.   
The most frequent symptoms in 60 poisoned patients 
were: hypotension (58 patients, 97%), nausea and vomiting 
(49 patients, 82%), loss of conscious (21 patients, 35%), 
abdominal pain (19 patients, 32%), tachypnea and shock 
(each of the 14 patients, 23%) and agitation (7 patients, 
12%). According to ECG disturbances, in all 60 poisoned 
patients, 50% (30 people) had normal sinus rhythm and in 
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another 30 patients, frequency of dysrhythmia was as 
follows: 16 (26.7%) patients had sinus tachycardia, 11 
(18.3%) patients had ventricular tachycardia and 3 (5%) 
patients had supra ventricular tachycardia. According to 
ABG analysis acidosis was seen in 20 patients (33.3%) 
patients. 
In a total of 60 patients, the average amount of BuCh 
level was 5163.25±2158.31 U/L. The minimum and 
maximum level of BuCh in the patients was 435 U/L and 
10076 U/L. In ZnP and ALP poisoned patients, the mean 
level of Buch was 5608±1577 U/L and 4721.46±2562U/L 
respectively (graph1). According to liver enzyme change 
(AST, ALT); only 1 (1.7%) patient had abnormal liver 
enzyme level. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Mean butyrylcholinesterase level in the participants 
 
Discussion 
Poisoning by pesticides is a common problem in 
developing countries. These properties are the best products 
for self- poisoning. Among them, poisoning with phosphide 
compounds such as ZnP and AlP is associated with a very 
high mortality. ZnP as a rodenticide is a gray-black powder 
with an odor similar to garlic. Ingestion of 1 gr of ZnP can 
cause toxicity in humans and death has been reported after 
ingestion of 4-8 gr (18). AlP exists as yellowish to dark gray 
granular or powdered solid which is formulated as tablets, 
pellets, or small sachets of powder and used as 
a rodenticide, insecticide, and fumigant for stored cereal 
grains. Each tablet contains 3 gr of ALP and ingestion of 1 – 
1.5 gr can be lethal (19, 20).  
 In our study, the average consumption of the ALP was 
2.5 gr and in Shadnia’s study was 5.1 gr (7). After exposure 
of these compounds to the air, moisture and gastric 
hydrochloric acid produce a highly toxic phosphine gas. 
Although the exact mechanism of phosphine toxicity is 
unknown but after rapidly absorbed throughout the 
gastrointestinal tract, leading to systemic toxic effects. The 
mechanism of toxicity includes failure of cellular respiration 
due to the effect on mitochondria, inhibition of cytochrome 
C oxidase and formation of highly reactive hydroxyl 
radicals. Cellular injury due to lipid peroxidation is also 
suggested. The exact underlying mechanism of 
cardiotoxicity and acute circulatory failure caused by 
phosphine is not well defined (20). There is a decrease in the 
level of catalase and increase in the activity of superoxide 
dismutase in patients of phosphine poisoning (21). Also, the 
reduction of glutathione concentration in different tissues 
explains the cellular injury as glutathione is a protecting 
factor against oxidation by catalysing the reduction of the 
oxygen peroxide in O2 and H2O (13). 
 Phosphine, either during inhalation or exhalation after 
ingestion, directly produces injury to the alveolar capillary 
membrane, in addition to oxidative injury leading to acute 
lung injury (20). Reducing the BuCh enzyme is one of the 
other effects of phosphine gas (17). Based on Al-Azzawi and 
Mittra’s studies which were done on the rat and the human 
serum exposed to phosphine, BuCh level decreased (15-16). 
In our study, during a-12 month period, 60 patients who 
were admitted due to poisoning by ZnP and ALP were 
evaluated. The results showed that there was no significant 
change in the BuCh level in phosphide compounds 
respecting the normal level and only in a small number of 
patients, enzyme reduction was observed. Despite the 
decrease of this enzyme in a small number of patients, no 
cholinergic symptoms and signs were observed. 
Self-poisoning with pesticides, especially phosphide 
compounds is one of the most common cases of poisoning 
among males and females. The prevalence varies between 
males and females in different parts of the world, as in the 
present study, the number of female ZnP poisoned patients 
were more than males, while in another study, male patients 
were more than females (9). Also, in our study, the number 
of ALP poisoned male patients was more than females, while 
in Shadnia’s study males and females were equal and in 
Soltaninejad’s study, males were more than females (7, 22).  
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Suicide by pesticides, as in other cases of deliberate 
poisoning is more common in young adults (23). The 
average age of patients in the present study was 32.8 years 
and most of them were between 20-30 years and in 
Shadnia’s study was 27.1 years and were between 20-30 
years (7). Due to the high toxicity of phosphide compounds, 
the mortality rate is very high and the most common cause of 
death usually is cardiac arrhythmias and cardiogenic shock 
(24). The mortality rate is highly variable, ranging from 37 
to 100%, and can reach more than 60%, even inexperienced 
and well-equipped hospitals (25).  
In this study, the fatality rate in ZnP and ALP poisoned 
patients was 16.7% and 33.3%, respectively, whereas in 
Trakulsrichai’s study ZnP fatality was 7 % (20) while in 
Soltaninejad’s and Bhalla’s studies, ALP fatality was 57.5% 
and 40%, respectively (22, 26). The most clinical 
manifestations include vomiting, abdominal pain, agitation, 
tachy dysrhythmias, tachypnoea, acidosis, hypotension, 
palpitation and unresponsive shock (24). In most studies, 
similar to our study, cardiovascular and gastrointestinal 
symptoms were the most clinical manifestations (7, 9). 
About 50% of our patients had dysrhythmia which was 
similar to the Soltaninejad’s study (22). The most 
dysrhythmias in our study were sinus tachycardia, 
ventricular tachycardia, supraventricular tachycardia while in 
Jha’s study was sinus tachycardia and sinus bradycardia 
(27). 
In this study, like the other studies, the most finding in 
ABG was acidosis and most patients who had severe 
acidosis died (7, 28).  
Considering that the present study was a case series study 
and carried out within a one – year period, a limited number 
of patients were assessed. On the other hand, regarding the 
fact that most of the studies measuring the cholinesterase 
enzyme have been performed on animal samples, 
comparison of the results of our study with other studies will 
be of limited value. Also, considering that it was not possible 
to measure the true cholinesterase enzyme of this medical 
center, it would be better to consider this issue in future 
studies. 
In Due to lack of a specific antidote, poisoning with ZnP 
and ALP still causes fatalities. Cardiovascular and GI tract 
symptoms were the most important clinical manifestations. 
These symptoms were more frequent in ALP poisoned 
patients. Most patients who had decreased of BuCh enzyme 
were ALP poisoning patients.  
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